• Super-Enhancer Regulation of KLF6 Drives Human Adipogenesis

  2026-06-08

  Nguyen et al. reveal how a super-enhancer (SE_00159) orchestrates the expression of KLF6, a key transcription factor, during the adipogenic differentiation of human adipose-derived stem cells (hADSCs). Their findings connect super-enhancer-mediated transcriptional regulation to the control of adipogenesis, offering new insight into the molecular architecture governing fat cell development.

• Enhanced Activity of Temafloxacin Against Gram-Positive Bact

  2026-06-07

  This review analyzes pivotal findings from Mandell et al. (1991) on the in-vitro activity of temafloxacin, revealing its superior efficacy over other quinolones against Gram-positive cocci, including penicillin-resistant Streptococcus pneumoniae. The study’s rigorous comparative approach provides actionable insights for antimicrobial research and infection model development.

• Necrostatin-1: Applied RIP1 Kinase Inhibition in Necroptosis

  2026-06-06

  Necrostatin-1 empowers researchers to dissect necroptosis mechanisms with precision, enabling reproducible inhibition of RIP1 kinase signaling in both in vitro and in vivo models. This guide translates recent literature and validated protocols into actionable workflows, troubleshooting advice, and advanced applications for disease modeling.

• A 83-01: Mechanistic Precision for Translational Organoid Re

  2026-06-05

  Explore how A 83-01, a selective ALK-5 inhibitor from APExBIO, is redefining translational research in TGF-β/Smad signaling, EMT, and organoid modeling. This thought-leadership article integrates recent advances in organoid technology, practical workflow guidance, and strategic outlooks for researchers aiming to bridge basic mechanistic insight with clinically relevant discovery.

• Dual Epigenetic Targeting Restores Antitumor Immunity in PTE

  2026-06-05

  The reference study demonstrates that EZH2 inhibition combined with 5-azacytidine reactivates suppressed immune pathways in PTEN-deficient glioblastoma by triggering viral mimicry. This dual epigenetic strategy remodels the tumor microenvironment, offering a promising direction for overcoming immunosuppression and therapeutic resistance in aggressive brain tumors.

• IWP-L6 Porcupine Inhibitor: Precision Wnt Modulation in Acti

  2026-06-04

  IWP-L6 empowers researchers to dissect Wnt signaling with sub-nanomolar precision, unlocking new insights into developmental biology and metabolic regulation. This guide translates recent breakthroughs and experimental best practices into actionable protocols, troubleshooting strategies, and advanced applications for APExBIO’s flagship Porcupine inhibitor.

• Cefazedone (Refosporen) Protocols: Applied Workflows and Tro

  2026-06-04

  Cefazedone (Refosporen) stands out for robust, β-lactamase-resistant antibacterial profiling across Gram-positive and Gram-negative pathogens. This guide translates cutting-edge research and validated clinical protocols into actionable workflows, troubleshooting insights, and comparative advantages for both in vitro and translational infection models.

• G418 Sulfate (Geneticin): Selection, Antiviral Use & Workflo

  2026-06-03

  Geneticin (G-418 Sulfate) excels as a dual-purpose tool for genetic engineering selection and antiviral research, thanks to its robust inhibition of ribosomal protein synthesis and proven efficacy in selective cell systems. This guide unpacks experimental workflows, advanced troubleshooting, and cross-domain insights to help researchers harness the full potential of G418 Sulfate in both classic and emerging applications.

• Aztreonam: Applied Workflows for Gram-Negative Resistance As

  2026-06-03

  Harness Aztreonam’s unique monocyclic β-lactam structure for targeted investigation of Gram-negative resistance, bone marrow toxicity, and hepatic enzyme modulation. This guide delivers protocol enhancements, troubleshooting insights, and practical translation of recent multidrug-resistant Enterobacter cloacae research.

• RITA (NSC 652287): Precision Tools for p53 Activation in Can

  2026-06-02

  RITA (NSC 652287) redefines p53 pathway research by providing selective, nanomolar-range cytotoxicity and robust MDM2-p53 inhibition, enabling advanced apoptosis assays and tumor xenograft models. This guide distills the latest experimental workflows, optimization strategies, and key troubleshooting insights for maximizing RITA’s research impact.

• Renal Npt1-Mediated Transport of Faropenem Sodium: Mechanist

  2026-06-02

  This study elucidates how the inorganic phosphate transporter Npt1 mediates the renal secretion of faropenem sodium, a penem antibiotic, using a Xenopus oocyte expression system. The findings clarify the molecular basis of faropenem's elimination, informing both pharmacokinetic studies and antibiotic resistance research.

• Methicillin Sodium Salt: Mechanistic Power and Strategic Imp

  2026-06-01

  This thought-leadership article explores how Methicillin sodium salt serves as both a mechanistic probe and a benchmark tool in Staphylococcus aureus infection research, providing translational scientists with critical guidance for experimental design, resistance modeling, and strategic decision-making. Integrating molecular insights and clinical context, the article positions APExBIO’s Methicillin sodium salt as a foundational standard for advancing the next generation of antimicrobial research.

• CGF Induces ROS-Mediated Cell Cycle Arrest in Colorectal Can

  2026-06-01

  This study identifies the natural compound Cya-Gly-Fer (CGF), extracted from purple sweet potato, as a potent inhibitor of colorectal cancer progression. By triggering ROS-mediated metabolic reprogramming and mitochondrial dysfunction, CGF induces cell cycle arrest and apoptosis, highlighting a promising therapeutic avenue and experimental model for cell cycle progression analysis.

• Cefazedone (Refosporen): Reliable Antibiotic Solutions for L

  2026-05-31

  This article explores real-world laboratory challenges in cell viability and antibacterial assays, demonstrating how Cefazedone (Refosporen) (SKU BA1102) ensures reproducibility, robust sensitivity, and workflow integrity. Researchers will find actionable guidance, protocol parameters, and candid vendor selection advice rooted in data and best practices.

• LINC01278 Suppresses Uveal Melanoma via mTOR Pathway Inhibit

  2026-05-30

  This study identifies LINC01278 as a novel autophagy-related lncRNA that inhibits uveal melanoma progression by suppressing the mTOR signaling pathway. These findings highlight the LINC01278–mTOR axis as a potential therapeutic target and provide mechanistic insights for future cancer research.

444 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page